These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34917047)

  • 1. Abundance of Lipopolysaccharide Heptosyltransferase I in Human Gut Microbiome and Its Association With Cardiovascular Disease and Liver Cirrhosis.
    Lin S; Zhang H; Wang X; Lin T; Chen Z; Liu J; Wang J
    Front Microbiol; 2021; 12():756976. PubMed ID: 34917047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease.
    Salguero MV; Al-Obaide MAI; Singh R; Siepmann T; Vasylyeva TL
    Exp Ther Med; 2019 Nov; 18(5):3461-3469. PubMed ID: 31602221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health.
    Jia B; Park D; Hahn Y; Jeon CO
    Gut Microbes; 2020 Sep; 11(5):1300-1313. PubMed ID: 32329665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biosynthesis of Lipooligosaccharide from
    Jacobson AN; Choudhury BP; Fischbach MA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
    Benten D; Schulze zur Wiesch J; Sydow K; Koops A; Buggisch P; Böger RH; Gaydos CA; Won H; Franco V; Lohse AW; Ray SC; Balagopal A
    BMC Gastroenterol; 2011 Oct; 11():107. PubMed ID: 21978390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling.
    d'Hennezel E; Abubucker S; Murphy LO; Cullen TW
    mSystems; 2017; 2(6):. PubMed ID: 29152585
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Panpetch W; Kullapanich C; Dang CP; Visitchanakun P; Saisorn W; Wongphoom J; Wannigama DL; Thim-Uam A; Patarakul K; Somboonna N; Tumwasorn S; Leelahavanichkul A
    mSystems; 2021 Jan; 6(1):. PubMed ID: 33436518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the human gut microbiome in liver cirrhosis.
    Qin N; Yang F; Li A; Prifti E; Chen Y; Shao L; Guo J; Le Chatelier E; Yao J; Wu L; Zhou J; Ni S; Liu L; Pons N; Batto JM; Kennedy SP; Leonard P; Yuan C; Ding W; Chen Y; Hu X; Zheng B; Qian G; Xu W; Ehrlich SD; Zheng S; Li L
    Nature; 2014 Sep; 513(7516):59-64. PubMed ID: 25079328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease.
    Fei N; Bruneau A; Zhang X; Wang R; Wang J; Rabot S; Gérard P; Zhao L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32019793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential Changes in the Mesenteric Lymph Node Microbiome and Immune Response during Cirrhosis Induction in Rats.
    Santiago A; Sanchez E; Clark A; Pozuelo M; Calvo M; Yañez F; Sarrabayrouse G; Perea L; Vidal S; Gallardo A; Guarner C; Soriano G; Manichanh C
    mSystems; 2019; 4(1):. PubMed ID: 30801032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.
    Yuan J; Baker SS; Liu W; Alkhouri R; Baker RD; Xie J; Ji G; Zhu L
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1292-8. PubMed ID: 24372861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal immunosuppressor induces stable gut microbiota after liver transplantation.
    Jiang JW; Ren ZG; Lu HF; Zhang H; Li A; Cui GY; Jia JJ; Xie HY; Chen XH; He Y; Jiang L; Li LJ
    World J Gastroenterol; 2018 Sep; 24(34):3871-3883. PubMed ID: 30228781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis.
    Carnevale R; Raparelli V; Nocella C; Bartimoccia S; Novo M; Severino A; De Falco E; Cammisotto V; Pasquale C; Crescioli C; Scavalli AS; Riggio O; Basili S; Violi F
    J Hepatol; 2017 Nov; 67(5):950-956. PubMed ID: 28716745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case-control study.
    Gui QF; Jin HL; Zhu F; Lu HF; Zhang Q; Xu J; Yang YM; Xiao C
    Infect Dis Poverty; 2021 Mar; 10(1):43. PubMed ID: 33771232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxonomic and Functional Compositions of the Small Intestinal Microbiome in Neonatal Calves Provide a Framework for Understanding Early Life Gut Health.
    Malmuthuge N; Liang G; Griebel PJ; Guan LL
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30658973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.